THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.
David Garcia, MD is a consultant for Bristol-Myer Squibb and PFizer, Daiichi Sankyo, CSL Behring, Boehringer-Ingelheim and Bayer.
Stephan Moll, MD is a consultant for Janseen Pharmaceuticals Inc. and Daiichi Sankyo.
The faculty members do plan on discussing unlabeled/investigational uses of a commercial product. Faculty will discuss the off-label use of apixaban and edoxaban for venous thromboembolism treatment.
Michael Burk, Boston University School of Medicine planner, has no relevant financial relationships with any commercial interest.
Patti-Ann Collins, DNP, MSN/MBA, RN, Boston University’s School of Medicine’s Lead Nurse Planner, has no relevant financial relationships with any commercial interest.
Christina Cove, MD Boston University’s Continuing Medical Education department’s independent CME content reviewer, has nothing to disclose with regards to commercial support.
Ms. Elizabeth Goldstein, Executive Director of Anticoagulation Forum, has nothing to disclose with regards to commercial support.
Elaine Hylek, MD Boston University’s School of Medicine CME Course Director, is a consultant for Bayer, Bristol Myers Squibb and Pfizer, Boehringer Ingelheim, Daiichi-Sankyo, and Johnson and Johnson. She also receives grant/research from Bristol Myers Squibb/Pfizer and Johnson and Johnson. She additionally has spoken at symposiums for Bayer, Boehringer Ingelheim and Bristol Myers Squibb/Pfizer.
Terri Schnurr, RN Anticoagulation Forum’s Nursing Course Advisor, has nothing to disclose with regards to commercial support.
Julie White, MS, Boston University School of Medicine planner, has no relevant financial relationships with any commercial interest.
Credit Designations/Accreditation Statements
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and Anticoagulation Forum. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Boston University School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This educational activity has been provided by Continuing Nursing Education Provider Unit, Boston University School of Medicine and co-provided by Anticoagulation Forum. Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
CNE Contact Hours: 1.0, all of which is pharmacology credit worthy.
Nurses will receive contact hours after completion of an evaluation and claim for credit form.
Continuing Pharmacy Education Credits
The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Attendance and completion of program evaluations at the conclusion of the program are required for a statement of credit. This knowledge-based activity is approved for 1.0 Contact Hours (0.1 CEUs). UAN: 0060-9999-14-059-H01-P. Expiration date: August 19, 2015.